Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenates
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (5) , 793-798
- https://doi.org/10.1016/0006-2952(88)90163-3
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- The Effect of Peroxisome Prouferators on Microsomal. Peroxisomal, and Mitochondrial Enzyme Activities in the Liver and KidneyDrug Metabolism Reviews, 1987
- Identification of DNA binding proteins from human cellsGene Analysis Techniques, 1986
- Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and manPharmacology & Therapeutics, 1985
- Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferatorBiochemical and Biophysical Research Communications, 1984
- Clobuzarit: Species differences in the morphological and biochemical response of the liver following chronic administrationToxicology and Applied Pharmacology, 1984
- Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamsterToxicology and Applied Pharmacology, 1984
- Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compoundsBiochemical and Biophysical Research Communications, 1983
- Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patientsAtherosclerosis, 1983
- The binding of long chain fatty acid CoA to Z, a cytoplasmic protein present in liver and other tissues of the ratBiochemical and Biophysical Research Communications, 1974
- MICROBODIES IN EXPERIMENTALLY ALTERED CELLSThe Journal of cell biology, 1967